Dailymed apomorphine dopamine agonist not opioid?

Is apomorphine on DailyMed as a dopamine agonist or an opioid?

Apomorphine is listed on DailyMed as a dopamine agonist (a dopamine receptor agonist). It is not an opioid and does not act on opioid receptors. DailyMed’s labeling for apomorphine describes it in the context of Parkinson’s disease treatment and dopaminergic receptor activity rather than opioid-mediated pain relief.

What does DailyMed say apomorphine is used for?

DailyMed labeling for apomorphine typically places it in dopaminergic therapy, commonly for “off” episodes in Parkinson’s disease (used as a rescue/rapid-acting treatment in the dopaminergic medication cycle). That positioning aligns with its role as a dopamine agonist rather than an analgesic/opioid drug.

Why are some people confused—does apomorphine have opioid-like effects?

Apomorphine’s main mechanism is dopaminergic stimulation, not opioid signaling. Any overlap in perceived effects (like nausea or drowsiness in some patients) can happen with many CNS-active drugs and does not make it an opioid. The key point from DailyMed labeling is mechanism class: dopamine agonist, not opioid.

Does DailyMed include “opioid” warnings or controls for apomorphine?

Because apomorphine is not an opioid, DailyMed labeling for it should not treat it as an opioid drug. Opioid risk language (such as those tied to opioid class boxed warnings or opioid-specific misuse risk frameworks) would not be expected if the label is correctly reflecting its pharmacologic class as a dopamine agonist.

If you share the exact DailyMed page link or the apomorphine product name (brand and formulation, such as injection pen vs vial), I can point to the specific “Drug Class” or “Mechanism of Action” wording from that label.